First Patients Dosed in PXS Scar Reduction Trial
30/01/2022 21:26
Australia Stock Exchange release from PHARMAXIS LTD PXS.AX : First Patients Dosed in PXS Scar Reduction Trial
- AU$37.28m
- AU$23.71m
- AU$6.84m
Australia Stock Exchange release from PHARMAXIS LTD PXS.AX : First Patients Dosed in PXS Scar Reduction Trial